248 related articles for article (PubMed ID: 26891251)
1. Multitarget Drugs: an Epigenetic Epiphany.
Ganesan A
ChemMedChem; 2016 Jun; 11(12):1227-41. PubMed ID: 26891251
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
3. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
[TBL] [Abstract][Full Text] [Related]
4. Histone modification therapy of cancer.
Biancotto C; Frigè G; Minucci S
Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
[TBL] [Abstract][Full Text] [Related]
5. Promises and challenges of anticancer drugs that target the epigenome.
Verbrugge I; Johnstone RW; Bots M
Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics 2.0: Special Issue on Epigenetics-Call for Papers.
Conway SJ; Arimondo P; Arrowsmith C; Jin J; Luo C; Meanwell N; Young W; Georg G; Wang S
J Med Chem; 2020 Nov; 63(21):12129-12130. PubMed ID: 33090784
[No Abstract] [Full Text] [Related]
7. Methyltransferases prefer monomer over core-trimmed nucleosomes as in vitro substrates.
Jiang Y; Schneck JL; Grimes M; Taylor AN; Hou W; Thrall SH; Sweitzer SM
Anal Biochem; 2011 Aug; 415(1):84-6. PubMed ID: 21459076
[TBL] [Abstract][Full Text] [Related]
8. Current limitations and future opportunities for epigenetic therapies.
Cherblanc F; Chapman-Rothe N; Brown R; Fuchter MJ
Future Med Chem; 2012 Mar; 4(4):425-46. PubMed ID: 22416773
[TBL] [Abstract][Full Text] [Related]
9. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
Eglen RM; Reisine T
J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
[TBL] [Abstract][Full Text] [Related]
10. KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
Simon RP; Robaa D; Alhalabi Z; Sippl W; Jung M
J Med Chem; 2016 Feb; 59(4):1249-70. PubMed ID: 26701186
[TBL] [Abstract][Full Text] [Related]
11. The "Epigenetic Code Replication Machinery", ECREM: a promising drugable target of the epigenetic cell memory.
Bronner C; Chataigneau T; Schini-Kerth VB; Landry Y
Curr Med Chem; 2007; 14(25):2629-41. PubMed ID: 17979715
[TBL] [Abstract][Full Text] [Related]
12. Histone post-translational modification: from discovery to the clinic.
Thomas NR
IDrugs; 2006 Jun; 9(6):398-401. PubMed ID: 16752306
[No Abstract] [Full Text] [Related]
13. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
Harrison IF; Dexter DT
Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
[TBL] [Abstract][Full Text] [Related]
14. Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with
Rabal O; San José-Enériz E; Agirre X; Sánchez-Arias JA; de Miguel I; Ordoñez R; Garate L; Miranda E; Sáez E; Vilas-Zornoza A; Pineda-Lucena A; Estella A; Zhang F; Wu W; Xu M; Prosper F; Oyarzabal J
J Med Chem; 2021 Mar; 64(6):3392-3426. PubMed ID: 33661013
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic chemical probes.
Müller S; Brown PJ
Clin Pharmacol Ther; 2012 Dec; 92(6):689-93. PubMed ID: 23093316
[TBL] [Abstract][Full Text] [Related]
16. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
Mai A; Altucci L
Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer and its association with chronic obstructive pulmonary disease: update on nexus of epigenetics.
Sundar IK; Mullapudi N; Yao H; Spivack SD; Rahman I
Curr Opin Pulm Med; 2011 Jul; 17(4):279-85. PubMed ID: 21537190
[TBL] [Abstract][Full Text] [Related]
18. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
Morera L; Lübbert M; Jung M
Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
[TBL] [Abstract][Full Text] [Related]
19. Chromatin-modifying enzymes as therapeutic targets--Part 1.
Keppler BR; Archer TK
Expert Opin Ther Targets; 2008 Oct; 12(10):1301-12. PubMed ID: 18781828
[TBL] [Abstract][Full Text] [Related]
20. Social isolation-induced epigenetic changes in midbrain of adult mice.
Siuda D; Wu Z; Chen Y; Guo L; Linke M; Zechner U; Xia N; Reifenberg G; Kleinert H; Forstermann U; Li H
J Physiol Pharmacol; 2014 Apr; 65(2):247-55. PubMed ID: 24781734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
